Amlodipine besylate

From WikiCover

Jump to: navigation, search

On July 9, 2007, Roxane Laboratories announced the approval of its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg by the U.S. Food and Drug Administration. The product is available in bottles of 90, and the 5mg and 10mg tablets are available in bottles of 300 and Unit Dose Blisters for immediate shipment to wholesalers and pharmacies nationwide.

Roxane Laboratories' Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg are AB rated to NORVASC(R) (amlodipine besylate)Tablets. Annual sales of Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg are approximately $2.7 Billion.

Retrieved from "http://www.wikicover.com/Amlodipine_besylate"